Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Foukakis

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
Cell|April 24, 2018
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell SequencingCharissa Kim, Ruli Gao, Emi Sei, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumorsTrisha Dwight, Srinivasan R Thoppe, Theodoros Foukakis, et al.
ESMO Open|November 11, 2020
PD-1 protein and gene expression as prognostic factors in early breast cancerAlexios Matikas, Ioannis Zerdes, John Lövrot, et al.
Eclinicalmedicine|February 5, 2024
Gonadotropin Releasing Hormone agonist (GnRHa) during chemotherapy and post-cancer childbirths - a Nationwide population-based cohort study of 24,922 women diagnosed with cancer in SwedenKenny A Rodriguez-Wallberg, Helle Kieler, Theodoros Foukakis, et al.
Journal of Imaging|November 10, 2022
Harmonization Strategies in Multicenter MRI-Based RadiomicsElisavet Stamoulou, Constantinos Spanakis, Georgios C Manikis, et al.
Molecular Oncology|March 3, 2020
Programmed death-ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21-gene and 70-gene signatures in estrogen receptor-positive diseaseIoannis Zerdes, Emmanouil G Sifakis, Alexios Matikas, et al.
Breast Cancer Research and Treatment|September 19, 2018
Prognosis in patients diagnosed with loco-regional failure of breast cancer: 34 years longitudinal data from the Stockholm-Gotland cancer registryClaudette Falato, Sara K Taylor, Robert Szulkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2016
An Endothelial Gene Signature Score Predicts Poor Outcome in Patients with Endocrine-Treated, Low Genomic Grade Breast TumorsNicholas P Tobin, Kristian Wennmalm, Linda S Lindström, et al.
Nature Medicine|July 8, 2024
AI-based selection of individuals for supplemental MRI in population-based breast cancer screening: the randomized ScreenTrustMRI trialMattie Salim, Yue Liu, Moein Sorkhei, et al.
Oncogene|December 21, 2004
Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogeneWeng-Onn Lui, Theodoros Foukakis, Johan Lidén, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
Cell|April 24, 2018
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell SequencingCharissa Kim, Ruli Gao, Emi Sei, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumorsTrisha Dwight, Srinivasan R Thoppe, Theodoros Foukakis, et al.
ESMO Open|November 11, 2020
PD-1 protein and gene expression as prognostic factors in early breast cancerAlexios Matikas, Ioannis Zerdes, John Lövrot, et al.
Eclinicalmedicine|February 5, 2024
Gonadotropin Releasing Hormone agonist (GnRHa) during chemotherapy and post-cancer childbirths - a Nationwide population-based cohort study of 24,922 women diagnosed with cancer in SwedenKenny A Rodriguez-Wallberg, Helle Kieler, Theodoros Foukakis, et al.
Journal of Imaging|November 10, 2022
Harmonization Strategies in Multicenter MRI-Based RadiomicsElisavet Stamoulou, Constantinos Spanakis, Georgios C Manikis, et al.
Molecular Oncology|March 3, 2020
Programmed death-ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21-gene and 70-gene signatures in estrogen receptor-positive diseaseIoannis Zerdes, Emmanouil G Sifakis, Alexios Matikas, et al.
Breast Cancer Research and Treatment|September 19, 2018
Prognosis in patients diagnosed with loco-regional failure of breast cancer: 34 years longitudinal data from the Stockholm-Gotland cancer registryClaudette Falato, Sara K Taylor, Robert Szulkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2016
An Endothelial Gene Signature Score Predicts Poor Outcome in Patients with Endocrine-Treated, Low Genomic Grade Breast TumorsNicholas P Tobin, Kristian Wennmalm, Linda S Lindström, et al.
Nature Medicine|July 8, 2024
AI-based selection of individuals for supplemental MRI in population-based breast cancer screening: the randomized ScreenTrustMRI trialMattie Salim, Yue Liu, Moein Sorkhei, et al.
Oncogene|December 21, 2004
Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogeneWeng-Onn Lui, Theodoros Foukakis, Johan Lidén, et al.
Pageof 13